Activin-A induces deviation of immune responses toward a type 2 phenotype, its serum concentrations increase dramatically in patients with CHC and they correlate with the serum levels of IL-6, TNF-α and the severity of liver damage associated with CHC [20, 23]. Here, IL6 is linked to cryohydrocytosis.